Keep Current with the Latest in Cell Biology Research
Block title
OFD1 Inhibition Induces BRCAness to Create a Therapeutic Vulnerability to PARP Inhibition in Pancreatic Cancer
[Nature Communications] Researchers identified oral-facial-digital syndrome 1 protein (OFD1) as a positive regulator of BRCA1 in human pancreatic cancer cells and specimens, with its overexpression correlating with poor prognosis.
Unraveling the Glyco-Immunity Nexus in Pancreatic Cancer
[Molecular cancer] With the help of new glycosylation signatures identified and techniques that allow scientists to reach single-cell resolution, they can target glycans and generate strategies to activate the immune system against PDAC.
The Immunomechanical Checkpoint PYK2 Governs Monocyte-to-Macrophage Differentiation in Pancreatic Cancer.
[Cancer Discovery] Researchers identified PYK2 as an immunomechanical checkpoint that drives monocyte-to-macrophage differentiation in PDAC via PIEZO1/integrin-mediated mechanical cues.
A RAS(ON) Multi-Selective Inhibitor Combination Therapy Triggers Long-term Tumor Control through Senescence-Associated Tumor-Immune Equilibrium in Pancreatic Ductal Adenocarcinoma.
[Cancer Discovery] Investigators showed that combining a RAS(ON) multi-selective inhibitor with the CDK4/6 inhibitor palbociclib drives persister cells into a senescent-like state, which coincides with improved tumor control and substantial remodeling of the tumor microenvironment.
March5-Mediated Trim28 Degradation Preserves Islet β-cell Function in Mice
[Nature Communications] Researchers identified March5 and Trim28 as key modulators of β-cell function. March5 is downregulated and Trim28 upregulated in islets from human or mouse with impaired glucose tolerance.
Oncolytics Biotech® to Engage FDA for Potential Registration-Enabled Study in First-Line Pancreatic Cancer with Goal to Launch Trial Activities by Year-End
[Oncolytics Biotech®, Inc.] Oncolytics Biotech® Inc. announced it has initiated regulatory discussions with the US FDA for a potential registration-enabled pivotal study in first-line metastatic PDAC.
Immunoregulatory Endothelial Cells Interact with T Cells after Myocardial Infarction
[Circulation Research] Scientists used single-cell RNA sequencing and spatial transcriptomics to identify endothelial cell states after acute myocardial infarction in mice.
Tricuspid Aortic Valve Regurgitation Associate with Ascending Aortic Aneurysm through Endothelial Activation and Lipoprotein Infiltration
[Arteriosclerosis Thrombosis and Vascular Biology] The authors investigated ascending aortic aneurysm initiation by assessing the relation between aortic regurgitation and vascular activation and inflammation.
COL1A1-Positive Endothelial Cells Promote Gastric Cancer Progression via the ANGPTL4-SDC4 Axis Driven by Endothelial-to-Mesenchymal Transition
[Cancer Letters] Scientists established a single-cell atlas of endothelial cells (ECs) in gastric cancer and identified a subpopulation of COL1A1+ ECs that play a critical role in tumor progression and metastasis.
Salk Professor Diana Hargreaves Earns V Foundation Award for Pancreatic Cancer Research
[Salk Institute] Salk Institute Professor Diana Hargreaves was named a 2025 All-Star Translational Award Program grantee by the V Foundation for Cancer Research.
Inhibition of FAK Promotes Pancreatic Cancer Immunotherapy by Mediating CXCL10 Secretion to Enhance CD8+ T Cell Infiltration
[Oncoimmunology] The authors analyzed single-cell sequencing datasets and clinical specimens to evaluate the role of focal adhesion kinase (FAK) in the immune response of pancreatic cancer.
Loss of Insulin-Positive Cell Clusters Precedes the Decrease in Islet Frequency and β-Cell Area in Type 1 Diabetes
[Diabetes] Investigators developed a whole-slide scanned image analysis pipeline for semiautomated quantitation of endocrine area, islet frequency, interislet distance, and endocrine object size distribution.